|
|
|
|
| LEADER |
01755nam a2200313 u 4500 |
| 001 |
EB002001902 |
| 003 |
EBX01000000000000001164803 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Cowling, Tara
|
| 245 |
0 |
0 |
|a Macrocyclic and linear gadolinium based contrast agents for adults undergoing magnetic resonance imaging
|h Elektronische Ressource
|b a review of safety
|c authors, Tara Cowling, Nina Frey
|
| 250 |
|
|
|a Version: 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2019, June 06, 2019
|
| 300 |
|
|
|a 1 PDF file (34 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Adult
|
| 653 |
|
|
|a Magnetic Resonance Imaging
|
| 653 |
|
|
|a Drug Evaluation
|
| 653 |
|
|
|a Gadolinium / adverse effects
|
| 653 |
|
|
|a Contrast Media
|
| 700 |
1 |
|
|a Frey, Nina
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK546000
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Contrast agents are widely used for magnetic resonance imaging (MRI) and angiography. These agents are administered intravenously and enhance the detail and clarity of images for more precise diagnoses. Although generally considered to be safe, the use of contrast agents may result in mild to severe adverse effects. The current Rapid Response report will seek to identify and synthesize the evidence around the risks and safety of macrocyclic and linear GBCAs for adults undergoing MRI.
|